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Poster Session-II 149the two thenwe will giveOndansetron IV during chemotherapy only
(day 1 and 2) and prescribe oral Ondansetron 16mg daily for five days
as the oral formulation is more cost effective.
Method:Nausea assessment will be completed of twenty patients
who are undergoing auto out patient SCT for Myeloma with a con-
ditioning regimen of high doseMelphalan. Ten of those patients will
receive IV Ondansetron 16mg day 1 through day 7 and ten will re-
ceive IV Ondansetron 16mg day 1 and 2 then oral Ondansetron
16mg on days 3 through 7. Patients will be asked to keep a log of their
nausea daily using a nausea assessment scale. The following scale will
be used; 05 not at all, 15 a little bit, 25 somewhat, 35 quite a bit,
45 verymuch. This scale is currently being used in our SCT follow-
up clinic. Cost will be calculated with the help of our pharmacy staff.
Interpretation: Data will be analyzed and presented and anti-
emetic recommendations will be made based on these patient out-
comes and costs of two different regimens.421
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MERS is an in house electronic system that facilitates all staff
members involved in patient care to anonymously report either an er-
ror or a near miss. Within the BMT program, the Quality Manage-
ment (QM) team usesMERS to improve the quality of care provided
to the pediatric BMT recipients. AnyMERS filed concerning pediat-
ric BMT patients are electronically sent to the Pediatric BMT QM
Nurse Coordinator daily. All events and near misses are distributed
to the chief of the Pediatric BMT Division, BMT Clinical Pharma-
cist, BMT CNS and BMT QM Medical Director. All events which
are considered as a sentinel event are acted on immediately. Monthly
meetings are held with the QM team to review all MERS reports.
Quarterly, all MERS reports are compiled and distributed into 6 cat-
egories including: Nursing, Pharmacy, Lab, Equipment, Falls and
Miscellaneous and are reviewed at our BMTQM Steering Commit-
tee Meetings. Performance improvement plans are developed based
on trends in the quarterly analysis. From September 2007–Septem-
ber 2008 90 MERS were reported concerning the pediatric BMT
population. The breakdown included: Nursing Error: 38%, Phar-
macy Error: 16%, Laboratory Error: 13%, Equipment Error 18%
Falls: 6% and Miscellaneous: 24%. Two performance improvement
initiatives were developed during this past year as a result of BMT
MERS reporting in the areas of Pharmacy and Equipment. MERS
filed by the BMTnursing staff was focused on anti - thymocyte glob-
ulin (ATG) and its location in themedication roomon the BMTunit.
Thismedication had no special label andwas not separated from sim-
ilar looking IV bags. Due to multiple MERS reported regarding the
danger of having the ATG bags within the same bin as the IVF bins,
a performance improvement plan was initiated including nursing and
pharmacy education and seperation of ATG bags from IVFs. Since
then, we have had no MERS reported on labeling or misadministra-
tion of ATG. Secondly, BMT nurses filedMERS on new IV connec-
tion caps that were causing splashes when the line was accessed,
difficulties in drawing blood, and increase CR-BSI. A performance
improvement plan resulted in change in caps and a subsequent reso-
lution of difficulties and reduction in CR-BSI. In summary, incident
reporting has a huge impact on the BMTQMprogram.These results
suggest that specific pediatric BMT incident reporting by an elec-
tronic system can result in change in practice and improvement in
quality of care to pediatric BMT recipients.422
SPIRITUALITY: THE ESSENTIAL SECRET
Burleson, J.K. Duke University Medical Center, Durham, NC
The subject of spirituality and it’s relation to health and specifi-
cally oncology, has risen to the forefront in nursing literature and re-search over the last decade. However, despite the increasing body of
literature on this topic, many healthcare providers feel ill prepared to
address a patient’s spiritual needs, and despite patients’ desire to dis-
cuss the topic, many providers ignore it altogether. A program was
developed for oncology healthcare providers with the purpose of re-
porting an integrative literature review, to increase participants un-
derstanding of spirituality as a concept with a broad definition to
encompass all patients. It also incorporated Parse’s nursing theory
of human becoming into this concept along with the key components
of spirituality, including a search for meaning, connectedness, and
survival of hope. These components were explored to purport the
importance of addressing spirituality with all patients, particularly
those in the oncology population, as existential questioning occurs
with a cancer diagnosis and patients struggle to find coping mecha-
nisms. The program also addressed the findings that the spirituality
of an oncology patient affects not only the patient, but the family as
a whole. The focus of patients and their caregivers may differ, thus
causing conflicts within a family. Ways to acknowledge these strug-
gles and interventions were discussed, providing a knowledge base
for providers. It is also important for the provider to understand
that to support a patient during a time of spiritual need or to address
spirituality as a piece of holistic care, the provider must first under-
stand his/her own spirituality. The audience participated in a short
spiritual exercise to direct them in exploring their own spiritual facet.
Spiritual assessment tools have improved over the last decade and are
available for clinical use. These were discussed and assessed as well.
Finally, interventions for patients in spiritual distress were discussed
in the form of an original acronym, REST. The findings of this lit-
erature review and program development will be presented as sec-
tions addressing the definitions of spirituality with the key
components found as commonalities throughout all definitions,
the importance of addressing spirituality, the affect of spiritual dis-
tress on the family, available assessment tools and their validity and
reliability, and interventions for spiritual distress, in the form of
REST, an original acronym.423
THE PRIMARY MYELOMA NURSE: AN EXPANDED ROLE OF THE TRANS-
PLANT COORDINATOR
Daily, K., Thirlwell, S. Moffitt Cancer Center, Tampa, FL
Traditionally, the role of the transplant coordinator in the care of
multiple myeloma (MM) patients is focused on coordination of
transplant screening, stem cell mobilization and collection, high
dose chemotherapy, stem cell rescue and post-transplant recovery.
The Moffitt Myeloma Program recognizes MM as a chronic disease
and provides comprehensive care over the entire continuum from di-
agnosis to end of life. Rather than ‘‘hopping from lily pad to lily pad’’
of care providers (from primary physician, to hematologist, to trans-
plant specialist then returning to hematologist), the patient experi-
ences unfragmented transitions in care through remissions and
exacerbations of MM. Within this novel model of care delivery,
the transplant coordinator has an expanded role as PrimaryMyeloma
Nurse (PMN). The role of the PMNmay be compared to that of pri-
mary nurses in the care of other chronic diseases such as chronic
heart failure and chronic obstructive pulmonary disease. A patient
is referred by their primary physician and will remain with the Mof-
fitt Myeloma Team for diagnosis, induction, possible transplant, re-
lapse treatment, clinical trials and end of life care. The PMN is ‘‘the
tie that binds’’, essential to linking all aspects of care and assisting im-
plementation of all phases of this trajectory. Beyond transplantation,
the PMN acquires knowledge and expertise of chemotherapy, novel
and experimental agents for induction and relapse treatment of MM.
The PMN establishes a stable therapeutic relationship and develops
a personalized plan of care for patients and families according to
their unique needs during each phase of MM. She ensures smooth
delivery of care in multiple locations including outpatient clinics,
outpatient infusion centers, inpatient units and the patient’s home.
At this time, the benefit of the novel role of PMN over that of tradi-
tional coordinator has not been examined. Our goal is to offer an al-
ternative approach to caring for MM as it has evolved into a chronic
disease. In the future, we hope that like a primary nurse of other
chronic diseases, a primary nurse for MM is recognized as beneficial
to patients and families.
